Trupanion, Inc. filings document the company’s pet medical insurance business, public-company governance, and capital structure. Form 8-K reports include quarterly and annual operating results, with disclosures on subscription revenue, enrolled pets, net acquisition cost, adjusted EBITDA, operating cash flow, and other measures used to describe the company’s insurance economics.
The filing record also covers material agreements, including credit facilities, secured borrowings, maturity terms, covenants, and limits on corporate actions. Proxy materials document director elections, board composition, executive compensation, equity awards, shareholder voting matters, and related governance disclosures.
Trupanion, Inc. Chief Financial Officer Fawwad Qureshi reported multiple share transactions involving common stock and restricted stock units. On February 25, 2026, he exercised 3,750 restricted stock units that convert into common stock on a one-for-one basis and received 3,750 common shares.
On the same date, he sold 4,645 common shares in an open-market transaction at a weighted average price of $25.61 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on May 19, 2025, meaning he had no discretion over timing. The weighted average sale price reflects multiple trades between $25.35 and $25.89 per share.
In addition, 913 common shares were withheld by the company at $26.70 per share to cover income tax obligations on the RSU vesting, which is described as not representing a sale. After these transactions, he directly owned 2,837 common shares and 26,250 RSUs.
TRUPANION, INC. executive Simon Wheeler, EVP, Trupanion International, reported routine equity compensation activity involving restricted stock units and common shares. On February 25, 2026, 322 restricted stock units were exercised and converted into 322 shares of common stock at a price of $0.00 per share.
Following this conversion, Wheeler directly owned 23,238 shares of common stock before a portion was withheld for taxes. Separately, 151 common shares were disposed of at $26.70 per share to satisfy income tax withholding and remittance obligations tied to the RSU vesting, leaving Wheeler with 23,087 directly owned common shares. Footnotes clarify this tax-related disposition does not represent an open-market sale by Wheeler.
TRUPANION, INC. Chief Legal Officer Asher Bearman reported routine equity compensation activity involving restricted stock units that convert into common stock on a one-for-one basis. On February 25, 2026, RSU conversions delivered 180 and 125 common shares at a stated price of $0.00 per share.
To satisfy income tax withholding tied to these vestings, the company withheld 68 and 48 common shares at $26.70 per share, which footnotes state do not represent sales by the insider. Following these transactions, Bearman directly owned 70,479 shares of Trupanion common stock.
TRUPANION, INC. Chief Operating Officer John R. Gallagher reported routine equity compensation activity involving restricted stock units that vested and converted into common stock. On February 25, 2026, RSUs converted into common shares on a one-for-one basis at no exercise price.
Gallagher acquired common stock through derivative exercises and had a portion of the newly vested shares withheld by the company to cover income tax obligations at a price of $26.70 per share, which the footnotes clarify does not represent an open-market sale. After these transactions, he directly held 37,670 shares of common stock.
Trupanion, Inc. Chief Revenue Officer Emily Dreyer reported routine equity activity linked to restricted stock units (RSUs). On February 25, 2026, RSUs covering 1,482 and 343 units converted into the same number of common shares on a one-for-one basis.
To cover income tax withholding on these vestings, 360 and 83 common shares were withheld by Trupanion at a price of $26.70 per share, which the footnotes state does not represent a sale by Dreyer. After these transactions, Dreyer directly owned 43,419 common shares.
TRUPANION, INC. executive Steve Weinrauch, EVP North America & Vet Strategy, reported multiple equity transactions on February 25, 2026 linked to previously granted restricted stock units (RSUs). Several RSU awards vested and converted into common stock on a one-for-one basis, increasing his direct holdings.
In connection with these vestings, the issuer withheld 129 and 9 shares of common stock at $26.70 per share to satisfy income tax withholding and remittance obligations, which the disclosure states do not represent sales by Weinrauch. He also completed an open-market or private sale of 85 common shares at $26.70 per share. Following these transactions, he directly owned 72,559 shares of Trupanion common stock.
John Gallagher filed a Form 144 reporting proposed sales of restricted common stock and recent dispositions. The filing lists proposed restricted shares of 430 (restricted on 02/25/2023) and 4,853 (restricted on 02/22/2026), and shows sales during the prior three months of 430 shares for $13,618.10 on 01/28/2026, 430 shares for $16,146.50 on 12/29/2025, and 6,383 shares for $222,282.87 on 11/28/2025.
FAWWAD QURESHI filed a Form 144 reporting an intended sale of 2,837 restricted common shares on 02/25/2026. The filing also shows 4,645 common shares were sold in the prior three months on 02/25/2026 for an aggregate of $118,958.45.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting the intended sale of 4,645 shares of Common Stock of TRUP issued as Restricted Stock on 02/22/2026. The filing also lists a prior sale by Fawwad Qureshi of 6,202 shares on 11/26/2025 for $219,836.09.
Trupanion, Inc. received an amended Schedule 13G/A from Tarmac DLTFM Limited reporting 0 shares beneficially owned of Trupanion common stock, representing 0% of the class. The filing identifies Guernsey as the filer’s citizenship and is dated 02/17/2026; it was signed on 02/25/2026.